𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predictors of response to exemestane as primary endocrine therapy in estrogen receptor–positive breast cancer

✍ Scribed by Hiroko Yamashita; Satoru Takahashi; Yukashi Ito; Toshinari Yamashita; Yoshiaki Ando; Tatsuya Toyama; Hiroshi Sugiura; Nobuyasu Yoshimoto; Shunzo Kobayashi; Yoshitaka Fujii; Hirotaka Iwase

Book ID
108586466
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
324 KB
Volume
100
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estrogen and progesterone receptors in t
Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy
✍ Andrea Manni; Baha'Uddin Arafah; Olof H. Pearson 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB 👁 2 views

This review presents our experience with the use of estrogen receptors (ER) and progesterone receptors (PgR) in the prediction of response to endocrine therapy in stage IV breast cancer. Presence of ER (>3 fmoUmg cytosol protein) significantly predicted response to the antiestrogen tamoxifen and to

Phase 2 randomized trial of primary endo
Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer
✍ Vladimir F. Semiglazov; Vladislav V. Semiglazov; Garik A. Dashyan; Elena K. Zilt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Abstract ## BACKGROUND. Few studies have compared primary neoadjuvant endocrine therapy with neoadjuvant chemotherapy in breast cancer patients. The need for preoperative chemotherapy with doxorubicin or taxanes may be reduced in postmenopausal patients with estrogen receptor (ER)‐positive and/